| Osteoclast differentiation |
2.20 |
0.00e+0 |
117/127 (92.13%) |
FOSB;JUNB;FCGR2A;...
|
| Neutrophil extracellular trap formation |
2.02 |
0.00e+0 |
101/189 (53.44%) |
SRC;CYBB;CLEC7A;...
|
| Antigen processing and presentation |
1.98 |
0.00e+0 |
60/78 (76.92%) |
HSPA8;CTSS;CTSB;...
|
| Natural killer cell mediated cytotoxicity |
1.88 |
1.05e-2 |
99/131 (75.57%) |
TNFSF10;ITGB2;PRKCA;...
|
| Pancreatic cancer |
1.88 |
1.12e-2 |
75/76 (98.68%) |
E2F2;VEGFA;TGFB1;...
|
| Measles |
1.86 |
1.17e-2 |
133/139 (95.68%) |
HSPA8;TNFAIP3;TLR2;...
|
| Bladder cancer |
1.79 |
2.80e-2 |
40/41 (97.56%) |
SRC;E2F2;DAPK1;...
|
| NOD-like receptor signaling pathway |
1.78 |
2.63e-2 |
145/181 (80.11%) |
CYBB;TNFAIP3;GBP2;...
|
| TNF signaling pathway |
1.76 |
2.80e-2 |
103/112 (91.96%) |
VCAM1;PTGS2;TNFAIP3;...
|
| Mitophagy |
1.75 |
2.80e-2 |
56/68 (82.35%) |
SRC;NBR1;GABARAPL1;...
|
| Leishmaniasis |
1.74 |
2.93e-2 |
67/77 (87.01%) |
PTGS2;CYBB;ITGB2;...
|
| Circadian rhythm |
1.74 |
2.69e-2 |
26/31 (83.87%) |
BHLHE41;PRKAG1;NPAS2
|
| Hepatitis B |
1.74 |
2.48e-2 |
151/162 (93.21%) |
SRC;E2F2;CXCL8;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.72 |
2.60e-2 |
97/100 (97%) |
VCAM1;CYBB;COL1A2;...
|
| Phagosome |
1.72 |
2.62e-2 |
118/152 (77.63%) |
CTSS;CYBB;CLEC7A;...
|
| Toxoplasmosis |
1.71 |
2.45e-2 |
103/112 (91.96%) |
HSPA8;LAMC2;LAMB3;...
|
| Herpes simplex virus 1 infection |
1.71 |
2.39e-2 |
165/498 (33.13%) |
SRC;TLR2;IFNAR2;...
|
| Chronic myeloid leukemia |
1.71 |
2.34e-2 |
72/76 (94.74%) |
E2F2;RUNX1;TGFB1;...
|
| Endocytosis |
1.70 |
2.51e-2 |
198/252 (78.57%) |
SRC;HSPA8;PIP5K1B;...
|
| GnRH secretion |
1.70 |
2.38e-2 |
60/64 (93.75%) |
PRKCA;KCNN4;GNAQ;...
|
| Influenza A |
1.69 |
2.27e-2 |
156/172 (90.7%) |
TNFSF10;TMPRSS4;CXCL8;...
|
| Epstein-Barr virus infection |
1.68 |
2.49e-2 |
189/202 (93.56%) |
E2F2;TNFAIP3;RELB;...
|
| Shigellosis |
1.68 |
2.38e-2 |
180/246 (73.17%) |
SRC;PRKCQ;CXCL8;...
|
| Hepatitis C |
1.66 |
2.98e-2 |
139/157 (88.54%) |
E2F2;IFNAR2;OAS1;...
|
| Tuberculosis |
1.66 |
3.14e-2 |
159/180 (88.33%) |
SRC;CTSS;CLEC7A;...
|
| Platelet activation |
1.65 |
3.18e-2 |
106/124 (85.48%) |
SRC;COL1A2;FCGR2A;...
|
| Toll-like receptor signaling pathway |
1.64 |
3.43e-2 |
94/104 (90.38%) |
CXCL8;TLR2;IFNAR2;...
|
| Lipid and atherosclerosis |
1.62 |
3.84e-2 |
190/215 (88.37%) |
SRC;HSPA8;VCAM1;...
|
| Lysosome |
1.62 |
3.72e-2 |
115/128 (89.84%) |
CTSS;CTSZ;CTSE;...
|
| Necroptosis |
1.61 |
3.65e-2 |
113/159 (71.07%) |
CYBB;TNFSF10;TNFAIP3;...
|
| Pentose and glucuronate interconversions |
-1.61 |
4.35e-2 |
17/34 (50%) |
GUSB;UGT2B28;UGP2;...
|
| Steroid hormone biosynthesis |
-1.61 |
4.37e-2 |
43/61 (70.49%) |
SULT2B1;HSD11B1;UGT2B28;...
|
| Pyruvate metabolism |
-1.66 |
3.10e-2 |
41/47 (87.23%) |
ADH1C;ALDH1B1;ACAT1;...
|
| Fat digestion and absorption |
-1.67 |
2.79e-2 |
35/43 (81.4%) |
PNLIPRP2;ABCA1;PLA2G12A;...
|
| Caffeine metabolism |
-1.67 |
2.89e-2 |
5/6 (83.33%) |
XDH;CYP1A2;CYP2A6;...
|
| Phenylalanine metabolism |
-1.68 |
2.76e-2 |
14/17 (82.35%) |
MAOA;ALDH3A1;GLYAT;...
|
| Ascorbate and aldarate metabolism |
-1.70 |
2.62e-2 |
15/30 (50%) |
GUSB;UGT2B28;ALDH9A1;...
|
| Renin-angiotensin system |
-1.72 |
2.17e-2 |
20/23 (86.96%) |
PREP;CTSG;ENPEP;...
|
| Arginine biosynthesis |
-1.74 |
2.06e-2 |
17/22 (77.27%) |
GLS2;GLS;ASS1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.75 |
2.20e-2 |
49/77 (63.64%) |
ALDH3A1;MGST2;HSD11B1;...
|
| Fatty acid degradation |
-1.79 |
1.48e-2 |
40/43 (93.02%) |
ACAA1;CPT2;ACADSB;...
|
| Steroid biosynthesis |
-1.85 |
7.50e-3 |
19/20 (95%) |
FDFT1;HSD17B7;LSS;...
|
| Glycine, serine and threonine metabolism |
-1.85 |
8.58e-3 |
31/40 (77.5%) |
PSAT1;ALAS1;BHMT;...
|
| Tyrosine metabolism |
-1.86 |
1.00e-2 |
30/36 (83.33%) |
TAT;ADH1C;TYRP1;...
|
| Complement and coagulation cascades |
-1.89 |
6.67e-3 |
76/85 (89.41%) |
KNG1;C4BPA;CFHR4;...
|
| PPAR signaling pathway |
-1.90 |
5.00e-3 |
66/74 (89.19%) |
ACOX2;LPL;ACAA1;...
|
| Drug metabolism |
-1.94 |
0.00e+0 |
78/151 (51.66%) |
MAOA;IMPDH1;HPRT1;...
|
| Mineral absorption |
-2.15 |
0.00e+0 |
48/60 (80%) |
CYBRD1;ATOX1;SLC30A1;...
|
| Retinol metabolism |
-2.41 |
0.00e+0 |
41/68 (60.29%) |
CYP1A1;DHRS9;ALDH1A1;...
|
